Synthesis of a biologically active triazole-containing analogue of cystatin A through successive peptidomimetic alkyne-azide ligations

Autor: Agnès F. Delmas, Vincent Aucagne, Ibai E. Valverde, Gilles Lalmanach, Fabien Lecaille
Přispěvatelé: Centre de biophysique moléculaire (CBM), Université d'Orléans (UO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Chimie du CNRS (INC), Pathologies Respiratoires : Protéolyse et Aérosolthérapie, Université de Tours (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Tours-Institut National de la Santé et de la Recherche Médicale (INSERM)
Jazyk: angličtina
Rok vydání: 2012
Předmět:
Azides
MESH: Cell Line
Tumor

Peptidomimetic
Molecular Sequence Data
Peptide
MESH: Amino Acid Sequence
010402 general chemistry
01 natural sciences
Catalysis
chemistry.chemical_compound
Cell Line
Tumor

Peptide synthesis
Peptide bond
Humans
Cystatin A
Neoplasm Invasiveness
[SDV.BBM]Life Sciences [q-bio]/Biochemistry
Molecular Biology

Amino Acid Sequence
MESH: Cystatin A
MESH: Cyclization
Peptide sequence
MESH: Peptidomimetics
MESH: Click Chemistry
ComputingMilieux_MISCELLANEOUS
chemistry.chemical_classification
MESH: Humans
MESH: Molecular Sequence Data
010405 organic chemistry
General Chemistry
General Medicine
MESH: Neoplasm Invasiveness
Triazoles
Native chemical ligation
Combinatorial chemistry
Cathepsins
MESH: Azides
0104 chemical sciences
chemistry
MESH: Triazoles
Cyclization
Alkynes
MESH: Cathepsins
Click chemistry
Click Chemistry
Chemical ligation
Peptidomimetics
MESH: Alkynes
Zdroj: Angewandte Chemie International Edition
Angewandte Chemie International Edition, Wiley-VCH Verlag, 2012, 51 (3), pp.718-22. ⟨10.1002/anie.201107222⟩
ISSN: 1433-7851
1521-3773
DOI: 10.1002/anie.201107222⟩
Popis: Amide surrogates are common in naturally occurring peptides and in synthetic peptides used in therapy. Whereas backbone-engineered proteins are, to date, extremely laborious to produce by genetic means, the advent of chemoselective peptide chemical ligation reactions paved the way to such complex molecular architectures of considerable potential for protein therapeutics. To date, the most popular strategy to introduce amide bond surrogates in proteins relies on an elaborate combination of 1) solutionphase synthesis to provide a suitably protected pseudo-dipeptide, 2) solid-phase peptide synthesis (SPPS) to incorporate the modification in a peptide fragment, and 3) native chemical ligation (NCL) to yield a full-length backbone-engineered protein. A valuable alternative for the introduction of amide-bond mimics in proteins would be a peptidomimetic ligation strategy combining in a single step the formation of the amide surrogate, its incorporation in a peptide backbone, and ligation of fragments. Besides the pioneering study on thioester backbone-engineered proteins, only few examples have been reported, including a recent study concerning a ligation of thioacidand aziridine-terminated model peptides, giving a reduced form (Y[CH2NH2]) of an amide bond. To enlarge the palette of the synthetic protein chemist, we envisioned developing a new peptidomimetic ligation prototype that leads to bioactive backbone-modified proteins. Herein, we report for the first time the use of the Cu-mediated cycloaddition of azides and terminal alkynes (CuAAC) for the assembly of unprotected peptide fragments into a bioactive triazole-containing protein.
Databáze: OpenAIRE